Prothena Corp Public (PRTA) Non-Current Deffered Revenue (2012 - 2025)

Prothena Corp Public (PRTA) recorded quarterly Non-Current Deffered Revenue of $1.6 million in Q1 2025, down 53.6% quarter-over-quarter from $3.4 million in Q4 2024, and down 97.63% on a YoY basis from $67.4 million in Q1 2024.

Prothena Corp Public (PRTA) Non-Current Deffered Revenue (2012 - 2025) Analysis & Trends

Prothena Corp Public's Non-Current Deffered Revenue history runs 14 years deep, the most recent figure standing at $1.6 million for Q1 2025.

  • In Q1 2025, Non-Current Deffered Revenue fell 97.63% year-over-year to $1.6 million; the TTM figure through Mar 2025 stood at $1.6 million (down 97.63% YoY), while the FY2024 annual figure was $3.4 million, down 94.88% from the prior year.
  • Non-Current Deffered Revenue was $1.6 million for Q1 2025 at Prothena Corp Public, down from $3.4 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $110.2 million in Q1 2021 to a low of $1.6 million in Q1 2025.
  • Historically, Non-Current Deffered Revenue has averaged $68.1 million across 5 years, with a median of $85.3 million in 2021.
  • The sharpest annual moves came in 2022 and 2025: Non-Current Deffered Revenue advanced 15.31% in 2022, then plunged 97.63% in 2025.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $102.9 million in 2021, then slipped by 17.14% to $85.3 million in 2022, then retreated by 20.97% to $67.4 million in 2023, then plunged by 94.88% to $3.4 million in 2024, then sank by 53.6% to $1.6 million in 2025.
  • The last three Non-Current Deffered Revenue figures came in at $1.6 million (Q1 2025), $3.4 million (Q4 2024), and $5.6 million (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Prothena Corp Public 479.08 Mn 149.61 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 1.60 Mn
Dec 31, 2024 3.45 Mn
Sep 30, 2024 5.60 Mn
Jun 30, 2024 7.37 Mn
Mar 31, 2024 67.41 Mn
Dec 31, 2023 67.41 Mn
Sep 30, 2023 67.41 Mn
Jun 30, 2023 67.41 Mn
Mar 31, 2023 85.29 Mn
Dec 31, 2022 85.29 Mn
Sep 30, 2022 96.99 Mn
Jun 30, 2022 98.35 Mn
Mar 31, 2022 100.64 Mn
Dec 31, 2021 102.93 Mn
Sep 30, 2021 104.56 Mn
Jun 30, 2021 85.29 Mn
Mar 31, 2021 110.24 Mn
Dec 31, 2020 110.24 Mn
Sep 30, 2020 110.24 Mn
Jun 30, 2020 110.24 Mn